| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/14/2002 | EP1231270A1 Novel protein and dna thereof |
| 08/14/2002 | EP1230931A1 Live bacterial vaccines for allergy treatment |
| 08/14/2002 | EP1230375A1 Inhibiting gene expression with dsrna |
| 08/14/2002 | EP1230368A2 Mammalian receptor proteins; related reagents and methods |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230357A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 08/14/2002 | EP1230346A2 Method for enhancing t cell reactivity toward tumour antigens |
| 08/14/2002 | EP1230338A1 Continuous-flow method for preparing microparticles |
| 08/14/2002 | EP1230255A1 25 human secreted proteins |
| 08/14/2002 | EP1230250A2 Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors |
| 08/14/2002 | EP1230242A1 Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230232A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1230214A2 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof |
| 08/14/2002 | EP1229942A1 Method and formula for tumor remission and suppression of cancer |
| 08/14/2002 | EP1229936A2 Use of anti-idiotypical antibodies as vaccines against cancer |
| 08/14/2002 | EP1229934A2 Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| 08/14/2002 | EP1229933A2 Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof |
| 08/14/2002 | EP1229932A2 Induction of mucosal immunity by vaccination via the skin route |
| 08/14/2002 | EP1229930A1 Compositions and methods for treatment of allergic disorders |
| 08/14/2002 | EP1229929A2 VACCINES FOR i MYCOPLASMA BOVIS /i AND METHODS OF USE |
| 08/14/2002 | EP1229919A2 A method of effecting phosphorylation in eucaryotic cells using thiamine triphosphate |
| 08/14/2002 | EP1229795A2 Human chemokine beta-13 |
| 08/14/2002 | EP0892642B1 Use in a composition of an extract of at least one labiate of the genus rosmarinarus, cultured in vitro |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0804164B1 Method of priming an immune response in a one-day old animal |
| 08/14/2002 | EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/14/2002 | EP0697876B1 Xenograft thymus |
| 08/14/2002 | CN1364193A BHV-1 gene-deleted virus vaccine |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364093A Improvement of T cell mediated immunity |
| 08/14/2002 | CN1364090A Medicinal compositions containing anti-Fas antibody |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1364080A Th2 differentiation inhibitors |
| 08/14/2002 | CN1363681A Activated lymphocyte from umbilical cord blood, preparations containing it as main content and method therefor |
| 08/14/2002 | CN1363365A Extraction of herbs by heating alcohol |
| 08/14/2002 | CN1363360A Bidirectional immunoregulating pill |
| 08/14/2002 | CN1363342A Nano medicine 'Mailuoning' and its preparing process |
| 08/14/2002 | CN1363340A Nano medicine 'Compound Jew's Ear' and its preparing process |
| 08/14/2002 | CN1363334A Nano medicine 'Dabuyin' and its preparing process |
| 08/14/2002 | CN1363302A Nano medicine 'Fangfeng Tongsheng' and its preparing process |
| 08/14/2002 | CN1363283A Beetoxin injection and its preparing process |
| 08/13/2002 | US6433197 Reacting arylhydroxy compound and an epoxy compound to form an epoxy-aryl ether; reacting epoxy-aryl ether with active methylene compound to form a lactone; reducing to provide hydroxy-substituted tetrahydrofuran |
| 08/13/2002 | US6433165 Chemokine receptor antagonists and methods of use therefor |
| 08/13/2002 | US6433148 Immunoglobulin antibodies with amino acid sequences |
| 08/13/2002 | US6433021 Antiinflammatory agents; mast cell stabilizers |
| 08/13/2002 | US6433009 Treatment of autoimmune, cardiovascular, nervous system, gastrointestinal, respiratory system, and viral disorders; antidiabetic, antiarthritic, antiinflammatory and antidepressant agents |
| 08/13/2002 | US6433008 Treating parkinson*s, alzheimer*s, autoimmune and rheumatic diseases; human immunodeficiency virus (hiv) dementia, and inflammation |
| 08/13/2002 | US6433001 1H-indole-3-glyoxylamide sPLA2 inhibitors |
| 08/13/2002 | US6432994 Cardiovascular disorders, glaucoma; antiinflammatory, wound healing, hypotensive, antiasthmatic, and antianaphylactic agents |
| 08/13/2002 | US6432973 Polyoxyethylated hydroxyesters of rapamycin useful in inducing immunosuppression and in the treatment of transplantation rejection, autoimmune diseases, solid tumors, fungal infections, and vascular disease. |
| 08/13/2002 | US6432972 Desloratadine as non-sedating antihistamine, decongestant |
| 08/13/2002 | US6432963 Antiinflammatory agents; tyrosine kinase inhibitor |
| 08/13/2002 | US6432962 Antiinflammatory agents |
| 08/13/2002 | US6432957 Piperazine derivative |
| 08/13/2002 | US6432949 Amide derivatives useful as inhibitors of the production of cytokines |
| 08/13/2002 | US6432947 N-heterocyclic derivatives as NOS inhibitors |
| 08/13/2002 | US6432935 Synergistic mixture of antibiotic, sulfadimidine and fungicide |
| 08/13/2002 | US6432917 Anticancer agents |
| 08/13/2002 | US6432659 Motor proteins and methods for their use |
| 08/13/2002 | US6432454 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators |
| 08/13/2002 | US6432445 Oil-free; bioavailability; useful as immunosuppressive agents, parasiticides, and agents for the reversal of multi-drug resistance |
| 08/13/2002 | US6432431 Steroid-containing cataplasms and process for producing the same |
| 08/13/2002 | US6432409 Hybrid peptides modulate the immune response |
| 08/13/2002 | US6432404 Methods of inhibiting locomotor damage following spinal cord injury with α D-specific antibodies |
| 08/13/2002 | CA2328851C Humanized immunoglobulins and their production and use |
| 08/13/2002 | CA2122604C Uses of aloe products, e.g. acemannan, in the treatment of diseases requiring intervention of the immune system for cure |
| 08/12/2002 | CA2369967A1 Methods of treating nuclear factor-kappa b mediated diseases and disorders |
| 08/08/2002 | WO2002061110A2 Nucleic acid derivatives |
| 08/08/2002 | WO2002061109A2 Yeast strains autonomously producing steroids |
| 08/08/2002 | WO2002061105A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 08/08/2002 | WO2002061086A2 Human leucine-rich repeat containing protein expressed predominately in small intestine, hlrrsi1 |
| 08/08/2002 | WO2002061033A2 Transfection of human embryonic stem cells |
| 08/08/2002 | WO2002060949A2 Glycoforms a fas ligand inhibitory protein analog |
| 08/08/2002 | WO2002060942A2 Protein modification and maintenance molecules |
| 08/08/2002 | WO2002060932A2 A serpin in bifidobacteria |
| 08/08/2002 | WO2002060931A2 A fimbria-like gene in bifidobacteria |
| 08/08/2002 | WO2002060927A1 Protein kinase signalling |
| 08/08/2002 | WO2002060924A2 Identification and applications of porcine reproductive and respiratory syndrome virus host susceptibility factor(s) for improved swine breeding and development of a non-simian recombinant cell line for propagation of the virus and a target for a novel class of antiviral compounds |
| 08/08/2002 | WO2002060919A2 Molecules with extended half-lives, compositions and uses thereof |
| 08/08/2002 | WO2002060903A1 Substituted indolines as 5-ht receptor ligands |
| 08/08/2002 | WO2002060900A2 Antagonists of mcp-1 function and methods of use thereof |
| 08/08/2002 | WO2002060898A1 Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060897A2 Process for making substituted 8-arylquinolinium benzenesulfonate |
| 08/08/2002 | WO2002060896A1 Ether derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060895A1 Diazocine derivatives and their use as tryptase inhibitors |
| 08/08/2002 | WO2002060894A2 Sulfonamide lactam inhibitors of factor xa |
| 08/08/2002 | WO2002060875A1 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 08/08/2002 | WO2002060867A2 Carbazole derivatives and their uses as heparanase inhibitors |
| 08/08/2002 | WO2002060864A1 Process of obtaining compositions of stable lutein and lutein derivatives |
| 08/08/2002 | WO2002060859A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 08/08/2002 | WO2002060495A1 Procedure and composition of treatment and/or care of the eye |
| 08/08/2002 | WO2002060492A1 Methods of inhibiting kinases |
| 08/08/2002 | WO2002060482A2 Perylenequinones for use with immunotherapy agents |
| 08/08/2002 | WO2002060481A1 Methods for treating disease states comprising administration of low levels of antibodies |
| 08/08/2002 | WO2002060480A1 Methods for treating or preventing skin disorders using cd2-binding agents |